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Abstract
Background: The case fatality rate of severely malnourished children during inpatient treatment is high and mortality
is often associated with diarrhea. As intestinal carbohydrate absorption is impaired in severe acute malnutrition (SAM),
differences in dietary formulations during nutritional rehabilitation could lead to the development of osmotic diarrhea
and subsequently hypovolemia and death. We compared three dietary strategies commonly used during the transition
of severely malnourished children to higher caloric feeds, i.e., F100 milk (F100), Ready-to-Use Therapeutic Food (RUTF)
and RUTF supplemented with F75 milk (RUTF + F75).
Methods: In this open-label pilot randomized controlled trial, 74 Malawian children with SAM aged 6–60 months, were
assigned to either F100, RUTF or RUTF + F75. Our primary endpoint was the presence of low fecal pH (pH ≤ 5.5)
measured in stool collected 3 days after the transition phase diets were introduced. Secondary outcomes were duration
of hospital stay, diarrhea and other clinical outcomes. Chi-square test, two-way analysis of variance and logistic regression
were conducted and, when appropriate, age, sex and initial weight for height Z-scores were included as covariates.
Results: The proportion of children with acidic stool (pH ≤5.5) did not significantly differ between groups before
discharge with 30, 33 and 23% for F100, RUTF and RUTF + F75, respectively. Mean duration of stay after transitioning was
7.0 days (SD 3.4) with no differences between the three feeding strategies. Diarrhea was present upon admission in 33%
of patients and was significantly higher (48%) during the transition phase (p < 0.05). There was no significant difference in
mortality (n = 6) between diets during the transition phase nor were there any differences in other secondary outcomes.
Conclusions: This pilot trial does not demonstrate that a particular transition phase diet is significantly better or worse
since biochemical and clinical outcomes in children with SAM did not differ. However, larger and more tightly controlled
efficacy studies are needed to confirm these findings.
Trial registration: ISRCTN13916953 Registered: 14 January 2013.
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Background
Severe Acute Malnutrition (SAM) affects an estimated
20 million children worldwide and results in high mor-
tality rates of up to half a million child deaths under the
age of five annually [1, 2]. SAM is defined by a weight-
for-height Z-score greater than three below the mean
(based on the 2006 WHO growth standards), a mid-
upper arm circumference (MUAC) of less than 115 mm
or by the presence of nutritional edema [3]. Severe acute
malnutrition differs from severe chronic malnutrition,
which manifests as stunting [1]. Severely malnourished
children without complications are currently treated as
outpatients in community-based management (CMAM)
programmes using specially formulated ready-to-use
therapeutic food (RUTF) [3]. However, children with
complicated SAM (i.e. SAM plus the presence of ‘danger
signs’ such as fever, absent appetite, pneumonia, dehy-
dration, severe edema) require inpatient treatment.
Therapeutic feeding for these children involves three
phases. In the stabilization phase, life-threatening prob-
lems are treated, the child is metabolically stabilized and
a low-protein milk-based formula diet, ‘F-75’, is provided.
Once appetite is regained, feeds are being finished and
edema has started to resolve, the child will be gradually
transitioned to a diet with a higher protein and energy
content. In this transition phase three nutritional strat-
egies are commonly used: F100, RUTF or RUTF supple-
mented with F75. The patient will enter the last stage of
nutritional rehabilitation, the rehabilitation phase, when
the child finishes all transition phase feeds and is clinic-
ally stable [3]. Mortality can reach up to 30% for compli-
cated SAM and often occurs within the first 48 h after
admission to a nutritional rehabilitation unit, i.e., during
the stabilization phase [4–6]. Nevertheless, mortality is
still substantial later during admission [4, 7] and even
after discharge [8].
Diarrhea is prevalent among severely malnourished
children and substantially increases their risk of death
[4, 5, 7, 9]. Enteric infections, the underlying malnutri-
tion and concurrent HIV disease affect the integrity,
morphology and absorptive function of the intestine
[10, 11]. ‘Environmental enteropathy’ can be associated
with reduced dissacharidases and subsequently lead to
impaired carbohydrate absorption, especially of lactose
[12–15]. Importantly, reduced carbohydrate absorption
can lead to severe osmotic diarrhea [16, 17].
The three main dietary regimens used in inpatient
treatment of children with SAM differ substantially, es-
pecially in their carbohydrate content and composition.
Lactose content is substantially higher in F100 and the
overall carbohydrate intake is expected to be highest in
RUTF + F75 [3]. Thus far, no studies have evaluated the
different dietary approaches in the nutritional rehabilita-
tion of malnourished children.
We performed an open-label pilot randomized clin-
ical trial to determine whether the use of transition
phase diets with different carbohydrate contents af-
fected fecal pH, length of stay and other clinical out-
comes in severely malnourished children.
Our main hypothesis was that RUTF + F75 would be
associated with a higher prevalence of acidic stool.
Methods
Study design, outcomes and ethics statement
This open-label pilot randomized controlled trial was car-
ried out in Blantyre, Malawi, from January to July 2013.
The primary outcome of this study was fecal pH, as a
measure of carbohydrate malabsorption, 3 days after the
start of the transition phase. Fecal pH of ≤5.5 was defined
as acidic stool and was considered suggestive of carbohy-
drate malabsorption [18]. Secondary outcomes included
duration of stay from the first day of the transition to dis-
charge from the ward, days with diarrhea, duration of
edema, weight at discharge, hypo- and hypernatremia, re-
version to F75 diet and mortality.
The sample size of 15 participants per group was based
on glucose malabsorption data obtained from our previous
study and calculated to detect a 20% difference in fecal pH
between groups with α = 0·05 and 80% power [17]. Covari-
ate adaptive randomization was used to achieve balance in
HIV status between groups, as HIV is an important covari-
ate. This was achieved by randomizing HIV positive and
negative children separately. We performed the procedures
according to the ethical standards of the Helsinki Declar-
ation. The trial was approved by the College of Medicine
Research and Ethics Committee of the University of Malawi
(P.005/11/1086).
Participants
Children were screened for eligibility at admission to
MOYO house (Nutrition Rehabilitation and Research
Unit of the Queen Elizabeth Central Hospital). Chil-
dren aged 6–60 months, diagnosed with SAM and
already admitted to the nutritional rehabilitation unit
(NRU) but still in the stabilization phase were in-
cluded in the TranSAM trial after written informed
consent. We included both HIV positive and negative
children, diagnosed by rapid antibody testing upon
admission. Exclusion criteria were admission to the
nutritional rehabilitation unit within the past year, se-
vere hemodynamic instability, haematocrit level ≤ 15%
and severe neurological symptoms. The study started
when a child entered the transition phase. When
clinically ready, a total of 74 patients were randomly
assigned to one of the transition phase dietary
regimens: F100 milk, RUTF only or RUTF+ F75 milk
(Fig. 1).
Versloot et al. BMC Pediatrics  (2017) 17:112 Page 2 of 8
Randomization and enrolment
Allocation concealment was achieved by using sealed, se-
quentially numbered opaque envelopes containing a label
for 1 of the 3 transition phase feeds. After written in-
formed consent, when patients were ready to start a tran-
sition phase diet, guardians were asked to open the next
numbered envelope showing their assigned group. The al-
location sequence was computer generated by an inde-
pendent collaborator. All legal guardians provided written
informed consent in either vernacular Chichewa or Eng-
lish. The trial was registered as ISRCTN13916953.
Study interventions
SAM patients were enrolled in the transition phase only
after they had been stabilized, gained appetite and, in the
case of kwashiorkor, edema had improved [3]. The full
amount of the three dietary transition phase regimes were
prescribed with the aim of a maximum energy intake of
135 kcal/kg/day. These regimes were based on WHO
guidelines and reference tables were used to calculate the
dietary amounts to be given based on body weight [3]. The
first group received F100 milk at the same frequency and
volume as F75 milk in the stabilization phase. The second
group received RUTF given alongside with water and the
amount of RUTF was increased as quickly as possible until
the target intake was reached. In the third group, F75 milk
was given as a top-up to RUTF to allow a gradual increase
of the amount of RUTF consumed by the child as well as
to ensure a minimum energy intake of 100 kcal/kg/day. We
used commercially available F75, F100 and RUTF (Nutriset,
Malaunay, France) (Table 1). The caregivers were given
color-coded milk cards corresponding to a specific diet.
Our research team was trained to distribute the correct
milk formulae to participants. Intake was monitored by re-
search nurses and assessed by the caregiver and these data
were recorded daily. If a child was clinically deteriorating in
the transition phase (e.g. loss of appetite; onset of one or
more WHO danger signs: shock/systemic illness, respira-
tory distress or impaired consciousness), the patient was
reverted to the stabilization phase and put back on F75
milk alone. A second transition phase was excluded from
analysis, but the failure of completing the initial transition
phase was documented.
Assessments
Clinical signs related to malnutrition were assessed and re-
corded daily by a group of 3 researchers during daily
rounds, using specifically designed paper-based case report
forms. The clinical signs included appetite, hydration status,
degree of edema and weight. Presence of diarrhea was de-
termined on admission to the hospital, the day before en-
tering the transition phase (Tbaseline), the first day of
transition (T0) and the next 3 consecutive days of treatment
(T1-T3 respectively). Diarrhea was defined as 3 or more
abnormal loose or watery stools. Severe diarrhea was de-
fined as more than 10 loose or watery stools. Diarrhea was
assessed by daily maternal recall. Data was entered in
Fig. 1 CONSORT diagram of severely malnourished children included in the study. RUTF, ready-to- use therapeutic food; SAM, severe
acute malnutrition
Table 1 Nutritional composition of ‘Transition Phase’ dietsa
F 75 F 100 RUTF
Carbohydrates
Lactose 11 34 19.5
Sucrose 4 9 22.9
Maltodextrin 58 9 0
Other CHO 0 0 2.1
Fat 17 33 32
Protein 6.2 12.5 13
RUTF ready-to-use therapeutic food, CHO carbohydrate
a Values are represented as grams per 100 g
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Access by a specific data manager and quality control was
performed by another member of the research team.
Two blood samples were taken: one just before entering
the transition phase and the other on transition day-3.
Blood was centrifuged within 1 h of collection and plasma
was stored at −80 °C for further biochemical analysis.
Feces was collected on the same days and immediately
stored at −80 °C.
Laboratory analyses
Plasma sodium was measured in the clinical laboratory of
University Medical Centre Groningen, The Netherlands,
using standard clinical laboratory techniques. Hyponatre-
mia was defined as a plasma sodium concentration of
<130 mmol/L and hypernatremia as >145 mmol/L. We
aimed to analyse reducing substances in the stool, but the
only commercially available method (Clinitest, Bayer,
Leverkussen, Germany) was no longer produced after the
study started, therefore, we removed this outcome meas-
ure from our study. Fecal pH-measurement was per-
formed using nitrazine paper (Micro Essential, Brooklyn,
NY, USA).
Statistical analysis
Descriptive statistics were presented as percentages for cat-
egorical variables and as mean with SD for continuous
ones. Baseline differences between groups were tested
using, as appropriate, Chi-square, Fisher’s exact test or two-
way analysis of variance (ANOVA). The associations be-
tween transition phase diets (F100, RUTF or RUTF +F75)
and the presence of acidic stool (pH ≤ 5.5), hyponatremia,
diarrhea were evaluated using logistic regression. Age, sex,
edema status and baseline weight-for-height Z scores were
included as covariates if they contributed significantly to
the models. Two-way ANOVA was used to test differences
in weight at discharge and duration of stay. For analysis of
hospital stay, the 6 children who died during transition
were excluded. A p value of <0.05 was considered signifi-
cant. All statistical analyses were conducted using SPSS
22.0 software (IBM, Armonk, NY, USA).
Results
A total of 86 children were enrolled in the study, of
whom 74 could be randomly assigned to a transition
phase diet (Fig. 1).
Children allocated to the 3 groups were similar with
respect to baseline patient and disease characteristics
(Table 2). HIV status with an overall prevalence of 35%
did not differ between groups. On admission, diarrhea
was common and seen in 33% of patients. All random-
ized children remained in the study and were followed
until discharge (n = 68) or death (n = 6).
Fecal pH
Acidic stool (pH ≤ 5.5) was present in 38% of patients
on admission, and in 29% 3 days after transition, but this
decrease in prevalence was not significant. Furthermore,
the average fecal pH was 5.8 ± 0.7 on admission and
6.1 ± 0.7 on transition day 3. Also, stool acidity did not
differ between diet groups 3 days post-transition (Fig. 2).
This suggests continuing carbohydrate malabsorption
during hospital admission.
Table 2 Patient and disease phenotype characteristics by assigned transition phase dieta
Characteristics Transition phase diet
F 100
(n = 25)
F 75 + RUTF
(n = 26)
RUTF
(n = 23)
P value
Age, months 24.8 ± 10.4 23.5 ± 10.7 22.8 ± 13.9 0.84
Female, n (%) 14 (56) 13 (50) 13 (57) 0.74
Weight at admission, kg 7.4 ± 2.1 8.2 ± 2.5 6.9 ± 2.4 0.16
MUAC at admission, cm 11.5 ± 1.8 12.1 ± 1.8 11.1 ± 1.9 0.15
Length at admission, cm 75.7 ± 7.7 77.4 ± 9.4 73.8 ± 8.9 0.36
Weight-for-height Z score, SD −3.2 ± 1.8 −2.5 ± 1.6 − 3.3 ± 1.7 0.21
Height-for-age Z score, SD −3.4 ± 2.2 −2.8 ± 1.9 − 3.2 ± 2.3 0.50
Kwashiorkor, n (%) 16 (64) 18 (69) 15 (65) 0.92
HIV positive, n (%) 10 (40) 9 (35) 7 (30) 0.78
Diarrhea prior to admission, n (%) 16 (64) 16 (62) 17 (74) 0.63
Diarrhea day of admission, n (%) 6 (26) 11 (44) 6 (27) 0.30
Hyponatremiab, n (%) 4 (16) 1 (4) 0 (0) 0.27
Hypernatremiac, n (%) 2 (8) 2 (8) 2 (9) 0.27
MUAC mid- upper arm circumference, RUTF ready- to- use therapeutic food
aValues are n (%) or means ± SDs
bHyponatremia before transition: plasma sodium concentration < 130 millimol per liter
cHypernatremia before transition: plasma sodium concentration > 145 millimol per liter
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Duration of hospital stay
On average, children were discharged 7.0 ± 3.4 days after
transitioning. We did not find significant differences in
duration of hospital stay between the three groups. In
HIV- positive patients, the mean duration of stay from
the first day of transition to higher caloric feeds until
discharge was significantly higher (P < 0.01) compared
to HIV negative patients, regardless of the intervention
(Fig. 3) but this effect was only marginal after correcting
for age (P = 0.07).
Diarrhea
Diarrhea was common in all patients irrespective of diet
group but was more prevalent during the transition
phase with an average of 48% compared to the first day
of admission (p < 0.05). This study did not find differ-
ences in diarrhea prevalence between dietary regimens
throughout the transition phase. The percentage of chil-
dren with diarrhea did not decrease during the analysis
period (Fig. 4).
Fig. 2 Percentage of children with acidic stool (pH ≤ 5.5) and
without acid stool (pH > 5.5) for each different dietary regimen.
Time point 1, day of admission, T3, the third day of transition
Fig. 3 Mean duration of hospital stay for children with SAM,
with and without HIV infection. Duration was measured from the
first day of transition until discharge from the clinic. Values are
shown as mean ± SD. Two- way ANOVA, * p < 0.05. RUTF,
ready- to- use therapeutic food; SAM, severe acute malnutrition
Fig. 4 Percentage of diarrhea for different time points during the
transition phase for each dietary regimen. Tbaseline, day before
entering transition phase, T0, first day of transition phase, T1-T3
the first 3 consecutive days of treatment
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Weight at discharge and weight change
In our study, weight at discharge between groups tended
to differ (P 0.09) (Table 3) but, after correcting for either
initial weight, weight-for-height Z-score or edema status,
this trend was not apparent. We also analysed weight
gain per day in children without edema separately be-
cause loss of residual edema is expected to influence
weight change in children with edema. For the non-
edema group, the mean weight gain per day in the tran-
sition phase was 27.1 g in the F75 + RUTF group and
42 g in the RUTF only group, opposed to the mean
weight loss of 6.6 g in the F100 group (Table 3).
However, this difference was not statistically significant.
Reversion to F75 diet and edema
A total of 9 children had a clinical deterioration in the
transition phase. Failure to transition appeared to be
more prevalent in the F100 group (n = 5), but this was
not statistically different. The mean duration of edema
was similar in all groups.
Hyponatremia, hypernatremia and mortality
Hyponatremia before transition was present in 6.9% of the
patients and hypernatremia in 8.3% of patients. At the
third day of transition both hyponatremia as well as
hypernatremia were equally present: 12.9%. In this study,
there were no statistically significant differences between
the groups. Mortality was 8% (n = 6) during the transition
phase to discharge. The mortality did not significantly dif-
fer between the three treatment groups (Table 3).
Discussion
To our knowledge, this study is the first to do a head-to-
head comparison of the three most commonly used dietary
regimens after initial stabilization of severely malnourished
children. The results from our pilot study do not support
the hypothesis that nutritional rehabilitation strategy with
the highest carbohydrate content is associated with a higher
percentage of patients with an acidic stool.
Studies have shown that diarrhea is very prevalent in
severely malnourished children and is associated with
worse clinical outcome [4, 5, 7, 9]. In low-resourced
countries diarrhea is often thought to be associated with
intestinal infections [7]. In addition, malnutrition itself
has also been associated with impaired integrity and ab-
sorptive function of the intestine [10, 11]. Studies have
indicated that carbohydrate malabsorption in general
and lactose intolerance specifically is prevalent in chil-
dren with SAM [13, 15, 19]. Based on small-bowel biop-
sies, reduced levels of dissacharidases, such as lactase,
have been observed in children with SAM [12, 19]. In
addition, monosacharide malabsorption has also been
found in children with SAM [17, 20]. Malabsorption of
these carbohydrates is well known to induce osmotic
diarrhea [16, 17, 21], but only a few studies have focused
on the possible relation between diet composition and
diarrhea in children with SAM [15, 19, 22].
Based on these studies we expected that providing se-
verely malnourished children with a combination of
RUTF + F75 (with potentially the highest carbohydrate
content, depending on intake of RUTF) or F100 (highest
lactose content) would lead to a higher incidence of
acidic stool (pH ≤ 5.5), diarrhea and a prolonged hos-
pital stay. Acidic stool (pH ≤ 5.5), indicative for carbohy-
drate malabsorption, was present in 38% of the children
in our study on admission and was 29% after 3 days of
transition. This is similar to the 26% carbohydrate mal-
absorption in malnourished children previously reported
[23]. Although we were unable to detect differences be-
tween groups, the mean fecal pH was nevertheless
greater than 5.5 in our study, which supports results ob-
tained from other studies of malnourished children [11,
22]. This may be explained by a number of things. First,
this was a pilot study with a relatively small sample size.
In our study 33% of severely malnourished children pre-
sented with diarrhea, which is lower than the 50–67%
described in previous literature [5, 9]. Although still sub-
stantial, this relatively lower prevalence of diarrhea in
Table 3 Clinical outcomes by assigned transition phase dieta
Transition phase diet
F 100
(n = 25)
F 75 + RUTF
(n = 26)
RUTF
(n = 23)
P value
Weight at discharge, kg 7.2 ± 2.2 7.9 ± 2.2 6.5 ± 2.1 0.09
Weight change per transition dayb, g −6.6 ± 63 27.1 ± 75.4 42 ± 33.5 0.34
Reverted back to F75, n% 5 (20) 1 (4) 3 (13) 0.21
Duration of edema, d 2.2 ± 2.9 2.7 ± 2.8 3.1 ± 3.6 0.61
Hyponatremia transition day 3, n (%) 5 (21) 2 (8) 2 (10) 0.35
Hypernatremia transition day 3, n (%) 1 (4) 4 (16) 5 (24) 0.16
Mortality, n (%) 1 (4) 2 (8) 3 (13) 0.52
aValues are n (%) or mean ± SD
bWeight change was only calculated for children without edema
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our cohort could have influenced the power to detect
differences in this outcome. All three nutrition rehabili-
tation diets contain a high amount of carbohydrates and
the differences in composition may not vary enough to
induce changes in the presence and severity of diarrhea
or in the overall clinical outcome.
We did not find a significant effect of different transi-
tion phase diets on hospital stay. However, the presence
of HIV infection may increase the duration of hospital
stay. HIV infected malnourished children have a varied
clinical presentation [6] and the underlying pathophysio-
logical mechanisms are potentially different from chil-
dren without HIV, although this is hardly studied [24].
Superimposed infections, including diarrhea, tubercu-
losis and extensive cutaneous infections are common
[25, 26] and complicate not only the clinical picture but
also the therapeutic response of children with SAM [27].
Disturbances in electrolytes are common in children
suffering from severe acute malnutrition. Electrolyte dis-
turbances can occur as a result of diarrhea, vomiting and/
or dehydration [28]. Clinically relevant hyponatremia was
present in 6.8% of the admitted children with SAM in our
study. The prevalence of hypernatremia at admission was
10,8%, which was lower than the previously reported
15.7% with the same cut- off value [28]. Before transition-
ing (T0), hyponatremia was present in 6.9% of the patients
and hypernatremia in 8.3% of the patients. Interestingly, 3
days after transition (T3) the percentage of patients with
hyponatremia and hypernatremia was 12.9% in both
groups. This coincided with an increase in diarrhea. The
lack of improvement in these clinical and biochemical pa-
rameters over time suggests an on-going enteropathy, per-
haps in part related to persistence of intestinal infections.
This could also be related to diet-induced osmotic diar-
rhea due to general malnutrition-related impairment in
intestinal function. Finally, all children receive antibiotic
treatment which could be involved in the on-going diar-
rhea. Total mortality after initial stabilization was still sub-
stantial in our study (8%). This is in line with previously
reported case series [4, 29, 30]. We did not find difference
in mortality between our interventions but our study was
not powered to detect differences in mortality rates.
This study shows that performing a trial to evaluate these
different dietary interventions is feasible. However, there
are a number of limitations that would need to be ad-
dressed. The sample size needs to be adequate to detect dif-
ferences in important outcomes such as mortality.
Secondly, challenges such as monitoring stool frequency
would need to be mitigated. Providing 24-h direct monitor-
ing of stool frequency would be ideal as maternal recall, al-
though commonly used, can be at times unreliable and is
prone to recall bias. Furthermore, we recommend monitor-
ing and supporting the caregivers during feeds, this would
avoid cases were caregivers may be switching or mixing
diets with those of other patients. This trial was an effective-
ness trial performed in a “real world” low income setting
with limited availability of research support staff. Also,
weight changes in the transition phase can be influenced by
hydration status and changes in edema for children with
kwashiorkor who often have not lost all their edema at that
time. Fully documenting these variables would be useful. In
the trial design ‘recovery rate expressed in incremental
weight/kg body weight/day was also listed as outcome
measure. However, this recovery rate was often unreliable
as children were discharged without increase in body
weight (especially in kwashiorkor). Without stringent
budget restrictions, it would have been interesting to evalu-
ate the effect of the three diets on microbiota as this is in-
creasingly recognized to play a role in SAM.
Conclusions
In conclusion, the results from this clinical trial do
sufficiently support the hypothesis that the varying
nutrient composition of three commonly used dietary
rehabilitation regimens (F75, F100 or RUTF) lead to
differences in outcomes in children with SAM. The
abnormal stool frequency and composition observed
throughout hospitalization suggest a sustained enter-
opathy. Future clinical trials focused on diarrhea
should aim to include more objective evaluation of
stool frequency and consistency to not rely on mater-
nal recall and include objective outcome measures of
intestinal function, such as macronutrient loss using
bomb calorimetry or carbohydrate content in stool
using, for example, mass spectrometry.
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